Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: A study by the Hellenic association of hematology

Transfusion and Apheresis Science

Volumn 46, Issue 2, 2012, Pages 173-180

  Tsirigotis, Panagiotis ^a   Kaloyannidis, Panayotis ^b   Papalexandri, Apostolia ^b   Baltadakis, Ioannis ^c   Karakasis, Dimitrios ^c   Batsis, Ioannis ^b   Sakellari, Ioanna ^b   Kitra, Vassiliki ^d   Goussetis, Evgenios ^d   Papageorgiou, Sotirios ^a   Spyridonidis, Alexandros ^e   Graphakos, Stelios ^d   Harhalakis, Nikolaos ^c   Dervenoulas, Ioannis ^a   Anagnostopoulos, Achilles ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Department of Hematology and Bone Marrow Transplantation   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d IASO GENERAL HOSPITAL   (Greece)

^e UNIVERSITY OF PATRAS   (Greece)

Author keywords

Extracorporeal photopheresis; Graft versus host disease; Relapse; Steroid refractory

Indexed keywords

CALCINEURIN INHIBITOR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THALIDOMIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE SEVERITY; DRUG WITHDRAWAL; EXTRACORPOREAL PHOTOPHERESIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHOTOTHERAPY; PRESCHOOL CHILD; RELAPSE; SCHOOL CHILD; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGY; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PHOTOPHERESIS; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; SURVIVAL RATE;

EID: 84858277606     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2011.09.001     Document Type: Article

References (36)

1. Lee S.J., Vogelsang G., Flowers M.E. Chronic graft versus-host disease. Biol Blood Marrow Transplant 2003, 9:215-233.
2. Wolff D., Gerbitz A., Ayuk F., Kiani A., Hildebrandt G.C., Vogelsang G.B., et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 2010, 16:1611-1628.
3. Socie G., Stone J.V., Wingard J.R., Weisdorf D., Henslee-Downey P.J., Bredeson C., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation: late effects working committee of the international bone marrow transplant registry. N Engl J Med 1999, 341:14-21.
4. Wolff D., Schleuning M., von Harsdorf S., Bacher U., Gerbitz A., Stadler M., et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011, 17:1-17.
5. Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987, 316:297-303.
6. Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Transf Apher Sci 2003, 29:61-70.
7. Bisaccia E., Palangio M., Gonzalez J., Adler K.R., Scarborough R., Goldberg S.L., et al. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy. J Clin Apher 2006, 21:181-187.
8. Couriel D., Hosing C., Saliba R., Shpall E.J., Andelini P., Popat U., et al. Extracorporeal photopheresis for acute and chronic graft-versus host disease: does it work?. Biol Blood Marrow Transplant 2006, 12:37-40.
9. Berger M., Pessolano R., Albiani R., Asaftei S., Barat V., Carraro F., et al. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report. J Pediatr Hematol Oncol 2007, 29:678-687.
10. Baird K., Wayne A.S. Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease. Transfus Apher Sci 2009, 41:209-216.
11. Filipovich A., Weisdorf D., Pavletic S., Socie G., Wingard J.R., Lee S.J., et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-955.
12. Pavletic S., Martin P., Lee S., Mitchell S., Jacobsohn D., Cowen E.W., et al. Measuring therapeutic response in chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant 2006, 12:252-266.
13. Martin P., Weisdorf D., Przepiorka D., Hirschfeld S., Farrell A., Rizzo J.D., et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of clinical trials working group report. Biol Blood Marrow Transplant 2006, 12:491-505.
14. Kim J.G., Sohn S.K., Kim D.H., Baek J.H., Lee K.B., Min W.S., et al. Impact of ABO-incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2005, 35:489-495.
15. Labopin M, Iacobelli S. Statistical Guidelines for EBMT. ; 2003. http://www.ebmt.org/1WhatisEBMT/Op_Manual/OPMAN_StatGuidelines_oct2003.pdf.
16. Kharfan-Dabaja M., Chavez J., Yu D., Zhu W., Fernandez-Vertiz E.I., Perkins J., et al. Severe hypoalbuminemia at day 90 predicts worse non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2011, 17:384-393.
17. Couriel D.R., Hosing C., Saliba R., Shpall E.J., Anderlini P., Rhodes B., et al. Extracorporeal photochemotherapy for the treatment of steroid resistant chronic GVHD. Blood 2006, 107:3074-3080.
18. Ilhan O., Arat M., Arslan O., Ayyildiz E., Sanli H., Beksac M., et al. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease. Transfus Apher Sci 2004, 30:185-187.
19. Rubegni P., Cuccia A., Sbano P., Cevenini G., Carcagnì M.R., D'Ascenzo G., et al. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease. Br J Haematol 2005, 130:271-275.
20. Flowers M., Apperley J., van Besien K., Elmaagacli A., Grigg A., Reddy V., et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008, 112:2667-2674.
21. Greinix HT, van Besien K, Elmaagacli AH, Hillen U, Grigg A, Knobler R, et al. For the UVADEX chronic GVHD study group. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis-results of a crossover randomized study. Biol Blood Marrow Transplant 2011 May 11 [Epub. ahead of print].
22. Lucid C.E., Savani B.N., Engelhardt B.G., Shah P., Clifton C., Greenhut S.L., et al. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant 2011, 46:426-429.
23. Foss F.M., DiVenuti G.M., Chin K., Sprague K., Grodman H., Klein A., et al. Prospective study of extracorporeal photopheresis in steroid refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005, 35:1187-1193.
24. Bladon J., Taylor P. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease. Ther Apher Dial 2008, 12:311-318.
25. Rubegni P., Sbano P., Cevenini G., Perari M.G., Marotta G., Risulo M., et al. CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy. Int J Immunopathol Pharmacol 2007, 20:801-807.
26. Di Biaso I., Di Maio L., Bugarin C., Gaipa G., Dander E., Balduzzi A., et al. Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. Transplantation 2009, 87:1422-1425.
27. Demirkiran A., Hendrikx T.K., Baan C.C., van der Laan L.J. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?. Transplantation 2008, 85:783-789.
28. Weiden P.L., Sullivan K.M., Flournoy N., Storb R., Thomas E.D. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981, 304:1529-1533.
29. Lee S.J., Klein J.P., Barrett A.J., Ringden O., Antin J.H., Cahn J.Y., et al. Severity of chronic graft versus-host disease: association with treatment-related mortality and relapse. Blood 2002, 100:406-414.
30. Weaver C.H., Clift R.A., Deeg H.J., Storb R., Appelbaum F.R., Bensinger W., et al. Effect of graft-versus host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia. Bone Marrow Transplant 1994, 14:885-893.
31. Bacigalupo A., Van Lint M.T., Occhini D., Gualandi F., Lamparelli T., Sogno G., et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood 1991, 77:1423-1428.
32. Kako S., Izutsu K., Oshima K., Sato H., Kanda Y., Motokura T., et al. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. Am J Hematol 2007, 82:937-939.
33. Hamaki T., Kami M., Momomura S., Mineishi S., Kusumi E., Kanda Y., et al. Sustained molecular remission in a patient with CML in blastic crisis receiving dose-reduced hematopoietic stem-cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon-alpha. Am J Hematol 2002, 71:196-199.
34. Suchin K.R., Cassin M., Washko R., Nahass G., Berkson M., Stouch B., et al. Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. J Am Acad Dermatol 1999, 41:980-986.
35. Marshall S.R. Technology insight: ECP for the treatment of GvHD - can we offer selective immune control without generalized immunosuppression?. Nat Clin Pract Oncol 2006, 3:302-314.
36. Knobler R., Jantschitsch C. Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma. Transfus Apher Sci 2003, 28:81-89.